Immunic Inc. (IMUX)
Symbol Info
Listed Symbol IMUX
Name Immunic Inc.
Share Info
Annual Info
Latest Fiscal Dividend Per Share $-
Latest Fiscal Date 2018-12-31
Latest Fiscal Revenue $-
Latest Fiscal EPS $-39.20
Price Info
21 Day Moving Average $11.5280
21 Day EMA $11.022620
50 Day Moving Average $12.9558
50 Day EMA $12.157180
200 Day EMA $29.066470
200 Day Moving Average 11.628110
52 Week High $46.80
52 Week Low $6.04
52 Week Change $-27.108800
Alpha -0.018683
Beta 3.5792
Standard Deviation 0.295038
R2 0.173737
Periods 60
Share Information
10 Day Average Volume 27,814
20 Day Average Volume 34,169
30 Day Average Volume 41,407
50 Day Average Volume 36,179
Outstanding Shares 10,093,454
Float Shares 9,759,237
Percent Float 96.69%
Short Interest -
Short Percent Float -
Short Interest Ratio -
Short Date
Holders
Institutions 102
Institute Holdings Date 2019-09-30
Institute Bought Previous 3 Months 101,831
Institute Holdings Percent 15.800000
Institute Sold Previous 3 Months 135,809
Insider Holdings Date
Insider Bought Previous 3 Months -
Insider Holdings Percent -
Insider Sold Previous 3 Months -
Insiders Shares Owned 334,217
Price Change
7 Day Price Change $-0.3900003
7 Day Percent Change -3.93%
21 Day Price Change $-4.4700003
21 Day Percent Change -31.91%
30 Day Price Change $-4.87
30 Day Percent Change -33.80%
Month To Date Price Change $-0.46
Month To Date Percent -4.60%
90 Day Price Change $-4.51
90 Day Percent Change -32.10%
Quarter To Date $-0.46
Quarter To Date Percent -4.60%
180 Day Price Change $-21.264
180 Day Percent Change -69.03%
200 Day Price Change $1.040000
200 Day Percent Change 12.24%
Year To Date $2.088000
Year To Date Percent 28.02%
Profile
Description Immunic Inc is a clinical stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing remitting multiple sclerosis, and psoriasis. The company is developing three small molecule products, IMU-838 is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH, IMU-935 is an inverse agonist of RORyt and IMU-856 targets the restoration of the intestinal barrier function.
Details
Issue Type CS
Market Cap $96,291,551
Sec Type
Auditor Baker Tilly Virchow Krause, LLP
Total Shares Outstanding 10,093,454
CEO Daniel Vitt
Employees 10
Last Audit UE
Classification
CIK 0001280776
Industry Biotechnology
Sector Healthcare
NAICS Research and Development in Biotechnology (except Nanobiotechnology)(541714)
Info
Address 11440 West Bernardo Court
Suite 300
San Diego, CA 92127
Website https://www.immunic-therapeutics.com
Facisimile +49 89 2500794 66
Telephone +49 89 2500794 60
Email info@immunic.de
Key Ratios
Profitability
EBIT Margin -
EBITDA Margin -
Pre-Tax Profit Margin -
Profit Margin Cont -
Gross Margin -
Profit Margin TOT -
Income Statements
Revenue $-
Revenue Per Share $-
Revenue 3 Years $-
Revenue 5 Years $-
Valuation Measures
PE Ratio -
Enterprise Value $64,813,540
Price To Sales -
Price To Free Cash -4.9
PE High Last 5 Years -
Price To Book 1.5
Price To Cash Flow -
PE Low Last 5 Years -
Price To Tangible Book 2.8
Financial Strength
Total Debt To Equity -
Int Coverage -
Current Ratio 7.0
Leverage Ratio 1.3
Quick Ratio 6.7
Long Term Debt To Capital -
Assets
Receivables Turnover -
Invoice Turnover -
Assets Turnover -
Management Effectiveness
Return Assets -137.26
Return On Equity -170.06
Return On Capital -159.65
Dividends
Dividend 3 Years $-
Dividend 5 Years $-
Ex Dividend Date
Dividend Rate $-
Dividend Yield -
Payment Type
Your Recent History
NASDAQ
IMUX
Immunic
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:us D:20191015 19:32:28